[Clinical study on coagulation, fibrinolysis, and complement systems after endoscopic injection sclerotherapy of esophageal varices with human thrombin].
D000368:Aged; D000706:Anaphylatoxins / Q000378:metabolism; D001777:Blood Coagulation; D001794:Blood Pressure / Q000187:drug effects; D003176:Complement C3 / Q000378:metabolism; D015926:Complement C3a; D003182:Complement C5 / Q000378:metabolism; D015936:Complement C5a; D004932:Esophageal and Gastric Varices / Q000097:blood / Q000628:therapy*; D004945:Esophagoscopy; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D013917:Thrombin / Q000627:therapeutic use*
D000706:Anaphylatoxins; D003176:Complement C3; D003182:Complement C5; D012597:Sclerosing Solutions; D015926:Complement C3a; D015936:Complement C5a; D013917:Thrombin